Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Mira Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +5 vs. Q4 2023
- Shares held
- 640.9K
- +544.1K (+561.9%) vs. Q4 2023
- Total value
- $704.0K
- +$602.0K (+590.1%) vs. Q4 2023
- New holders
- 9
- 1 more added
- Sold out
- 4
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $2.19M |
| Q1 2026 | 26 | $2.30M |
| Q4 2025 | 25 | $3.35M |
| Q3 2025 | 29 | $1.89M |
| Q2 2025 | 20 | $1.21M |
| Q1 2025 | 19 | $949.1K |
| Q4 2024 | 24 | $1.28M |
| Q3 2024 | 15 | $1.08M |
| Q2 2024 | 11 | $454.0K |
| Q1 2024 | 11 | $704.0K |
| Q4 2023 | 6 | $102.0K |
| Q3 2023 | 3 | $3.72K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Mira Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 4,771 | $5.25K | 0.00% | +4,771 | New |
| Cary Street Partner Investment Advisory LLC | 10,000 | $11.0K | 0.00% | +10,000 | New |
| Susquehanna International Group, LLP | 15,573 | $17.1K | 0.00% | +15,573 | New |
| First American Bank | 20,000 | $22.0K | 0.00% | +20,000 | New |
| Northern Trust Corp | 20,454 | $22.5K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 25,544 | $28.1K | 0.00% | +25,544 | New |
| Praetorian Wealth Management, Inc. | 27,500 | $30.3K | 0.01% | +27,500 | New |
| HRT Financial LP | 30,651 | $33.0K | 0.00% | +30,651 | New |
| Suncoast Equity Management | 40,000 | $44.0K | 0.01% | +40,000 | New |
| Virtu Financial LLC | 63,055 | $69.0K | 0.01% | +48,397+330.2% | Added |
| Cross Staff Investments Inc | 383,401 | $421.7K | 0.36% | +383,401 | New |
| GTS Securities LLC | 0 | $0 | 0.00% | −37,852−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −10,375−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |